In the course of searching for novel compounds that bind to the 50S subunit of the bacterial ribosome and inhibit protein synthesis, we have found a novel antibiotic with potent activity against Gram-positive bacteria and anaerobes. The antibiotic, neoberninamycin, is produced by a strain of Micrococcus luteus isolated from a soil sample taken in Highbridge, New Jersey. In this note, we describe the taxonomy of the producing organism, the production, isolation, physico-chemical and biological properties of this novel antibiotic, as well as its relationship to the known sulfur-containing peptide antibiotic, berninamycin A.
Taxon omy
The producing organism is a Gram-positive coccus with the cells arranged in tetrads and irregular clumps of tetrads. The colonies are yellow; the mol % G+C of the DNA is 67. These data place the organism in the genus NaCl and CH2C12 in the manner described above to yield a brown oil. Purification of the brown oil then proceeded as described for the orange oil obtained from the cell extract.
Physico-chemical Properties and Structural Relationship
The UV spectrum of neoberninamycin exhibits a maximum in CH3CN at 240nm (E}?m 360) (Fig. 1) 
Biological Properties
The results of agar dilution assays against a panel of aerobic and anaerobic bacteria are shown in Table 1 . Although inactive against Gram-negative aerobes, neoberninamycin is very active against Gram-positive aerobes and Grampositive and Gram-negative anaerobes.
Because of the similarity of the physicochemical properties of neoberninamycin and berninamycin A, we investigated the possibility that they have the same modeof action, i.e., inhibition of protein synthesis through an interaction with the 50S ribosomal subunit. Thompsonet alS* have provided evidence that berninamycin and thiostrepton have similar mechanisms of action. This conclusion was based, in part, on the observation that neither antibiotic is active against organisms carrying a resistance determinant from Streptomyces azureus that catalyzes the O-methylation of adenosine in 23S RNA. This methylation occurs at a single, specific site at which the ribo- Neoberninamycin, berninamycin A and thiostrepton weretested on two strains of Streptomyces lividans: A wild type (1326) and a strain (3131) carrying the S. azureus resistance determinant (pIJ702).
As shown in Table 2 , the strain with methylated ribosomes was not inhibited by any of the antibiotics at levels that inhibited growth of the control strain. These cross-resistance data suggest that neoberninamycin acts by the inhibition of protein synthesis through an interaction with the 50S ribosomal subunit. This is not unexpected in light of the physico-chemical similarities between neoberninamycin and berninamycin A.
Thus neoberninamycin, produced by M. luteus, is a new antibiotic very closely related to the streptomycete product, berninamycin, but clearly differentiated from it by its mass and :H NMRspectra.
